Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (171-180 of 270) with videos related to

Pageof 27
Sort By:
Diagnostics (Basel, Switzerland)|August 6, 2020
Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary HypertensionJorge Nuche, Teresa Segura de la Cal, Carmen Jiménez López Guarch, et al.
Data in Brief|April 5, 2017
Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA classAlejandro Santos-Lozano, Paz Sanz-Ayan, Laura González-Saiz, et al.
Journal of Internal Medicine|February 20, 2022
Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registryMaría Lázaro Salvador, Luis Rodríguez-Padial, Clara Soto Abánades, et al.
Revista Espanola De Cardiologia|October 8, 2004
[Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results]Carmen Jiménez López-Guarch, Pilar Escribano Subias, Rocío Tello de Meneses, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2022
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertensionMarc Humbert, Gérald Simonneau, David Pittrow, et al.
Heart and Vessels|April 6, 2020
Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm developmentJorge Nuche, José Manuel Montero-Cabezas, Ana Lareo, et al.
Annals of Translational Medicine|July 20, 2018
Physical activity levels are low in patients with pulmonary hypertensionLaura González-Saiz, Alejandro Santos-Lozano, Carmen Fiuza-Luces, et al.
Medicina Clinica|December 6, 2005
[Pulmonary hypertension during exercise in toxic oil syndrome]Rocío Tello de Meneses, Agustín Gómez de la Cámara, María Antonia Nogales-Morán, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 5, 2003
Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patientsJuan F Delgado, Violeta Sánchez, Carlos S de la Calzada, et al.
Mbio|September 9, 2025
Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?Hans Carolus, Judith Díaz-García, Vladislav Biriukov, et al.
Pageof 27

Showing results (171-180 of 270) with videos related to

Sort By:
Pageof 27
Diagnostics (Basel, Switzerland)|August 6, 2020
Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary HypertensionJorge Nuche, Teresa Segura de la Cal, Carmen Jiménez López Guarch, et al.
Data in Brief|April 5, 2017
Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA classAlejandro Santos-Lozano, Paz Sanz-Ayan, Laura González-Saiz, et al.
Journal of Internal Medicine|February 20, 2022
Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registryMaría Lázaro Salvador, Luis Rodríguez-Padial, Clara Soto Abánades, et al.
Revista Espanola De Cardiologia|October 8, 2004
[Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results]Carmen Jiménez López-Guarch, Pilar Escribano Subias, Rocío Tello de Meneses, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 20, 2022
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertensionMarc Humbert, Gérald Simonneau, David Pittrow, et al.
Heart and Vessels|April 6, 2020
Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm developmentJorge Nuche, José Manuel Montero-Cabezas, Ana Lareo, et al.
Annals of Translational Medicine|July 20, 2018
Physical activity levels are low in patients with pulmonary hypertensionLaura González-Saiz, Alejandro Santos-Lozano, Carmen Fiuza-Luces, et al.
Medicina Clinica|December 6, 2005
[Pulmonary hypertension during exercise in toxic oil syndrome]Rocío Tello de Meneses, Agustín Gómez de la Cámara, María Antonia Nogales-Morán, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 5, 2003
Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patientsJuan F Delgado, Violeta Sánchez, Carlos S de la Calzada, et al.
Mbio|September 9, 2025
Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?Hans Carolus, Judith Díaz-García, Vladislav Biriukov, et al.
Pageof 27